Derma Sciences, Inc (DSCI)

[BioSpecialist]

RUNUP HAS JUST BEGUN //Get on board NOW to make real money before the stock gets Discovered.


This Unknown Gem awaiting 2x FDA Approvals and Major Phase 2 Results for their Flapship product DSC127 this month or early Feb 2011 .DSCI has already a great profitable wound care business .

We could see 25-30$ quckily with only 1-2 million shares on the Float.


Derma Science (DSCI)

Market Cap: 32 Mil
Price: 4.90

Shares Outstanding: 6.5 Mil.....(Held by Insiders: 3 Mil )


In early 3Q10 the Company submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for MEDIHONEY® Gel Wound & Burn Dressing. This latest MEDIHONEY line extension is dispensed from a tube and is comprised of Active Manuka (Leptospermum) Honey blended with gelling agents. It is intended for use in hard-to-dress areas and wounds.



"We were very pleased to complete patient enrollment at the end of September in our Phase II trial with DSC127 in diabetic wound healing. We anticipate reporting top-line efficacy data between late December and mid January. Should the trial be successful, we are evaluating several options, including bringing on a partner.